Wikipedia:Articles for deletion/MDLIVE
Appearance
- The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
The result was delete. 78.26 (spin me / revolutions) 16:26, 18 November 2020 (UTC)
[Hide this box] New to Articles for deletion (AfD)? Read these primers!
- MDLIVE (edit | talk | history | protect | delete | links | watch | logs | views) – (View log)
- (Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)
Fails WP:NCORP. Non-notable small private company. scope_creepTalk 10:46, 31 October 2020 (UTC)
- Note: This discussion has been included in the list of Medicine-related deletion discussions. Spiderone 10:54, 31 October 2020 (UTC)
- Note: This discussion has been included in the list of Companies-related deletion discussions. Spiderone 10:54, 31 October 2020 (UTC)
- Note: This discussion has been included in the list of Florida-related deletion discussions. Spiderone 10:54, 31 October 2020 (UTC)
- Note: This discussion has been included in the list of Websites-related deletion discussions. CAPTAIN RAJU(T) 11:53, 31 October 2020 (UTC)
- Delete If you remove their own website as a source and the press releases, not much is left, so it doesn't meet notability guidelines. Expertwikiguy (talk) 04:41, 1 November 2020 (UTC)
- Keep Sig coverage in both Reuters and STAT News. Natureium (talk) 00:44, 4 November 2020 (UTC)
- Comment Examining the references;
- [1] Company page. Fails WP:SIRS, WP:SPIP.
- [2] Company page. Fails WP:SIRS, WP:SPIP.
- [] Unable to open.
- [3] Company page. Fails WP:SIRS, WP:SPIP.
- [4] Press-release. Dependent coverage. Fails WP:SIRS
- [5] Fails WP:CORPDEPTH
standard notices, brief announcements, and routine coverage, such as: of a product or a product line launch, sale, change, or discontinuance
- [6] Fails WP:CORPDEPTH
standard notices, brief announcements, and routine coverage, such as: of the expansions, acquisitions, mergers, sale, or closure of the business,
Sculley has an undisclosed stake and sits on the board of directors of Florida-based MDLive, a company that provides patients with remote access to a licensed physician. Sculley said he sees telemedicine and online mental health services “going mainstream” in coming years.... On MDLive’s mobile app and website, patients can consult a doctor for $49 per visit. MDLive claims its network of board certified physicians can treat a variety of ailments, such as allergies, infections and sports injuries Passing mention. Fails WP:SIRS. Not-indepth, merely reporting on the service. Fails WP:ORGIND. - [] Unable to open.
- [7]. MDLIVE Secures $23.6 Million in Funding led by Heritage Group and Sutter Health Fails WP:CORPDEPTH
standard notices, brief announcements, and routine coverage, such as: of a capital transaction, such as raised capital
- [8] Company page. Fails WP:SIRS, WP:SPIP.
Examining these, we find 3 are company pages, 3 fail CORPDEPTH as routine announcements, 2 dead links, 4 fails WP:SIRS as either dependent sources or self-published. The Reuter is two small paragraphs that don't constitute in-depth analysis an fail WP:SIRS. scope_creepTalk 10:05, 5 November 2020 (UTC)
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, Clarkcj12 (talk) 09:07, 8 November 2020 (UTC)
Please add new comments below this notice. Thanks, Clarkcj12 (talk) 09:07, 8 November 2020 (UTC)
- It is difficult to see how this is notable in any shape or form, so I am also going with Delete. Foxnpichu (talk) 12:25, 8 November 2020 (UTC)
- Delete I agree with the above analysis of sources, none of the references meets the criteria for establishing notability, topic fails GNG/NCORP. HighKing++ 17:18, 11 November 2020 (UTC)
- The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.